Objective-The lymphatic vascular system exerts major physiological functions in the transport of interstitial fluid from peripheral tissues back to the blood circulation and in the trafficking of immune cells to lymph nodes. Previous studies in global constitutive knockout mice for the lymphatic transmembrane molecule podoplanin reported perinatal lethality and a complex phenotype with lung abnormalities, cardiac defects, lymphedema, blood-filled lymphatic vessels, and lack of lymph node organization, reflecting the importance of podoplanin expression not only by the lymphatic endothelium but also by a variety of nonendothelial cell types. Therefore, we aimed to dissect the specific role of podoplanin expressed by adult lymphatic vessels. Approach and Results-We generated an inducible, lymphatic-specific podoplanin knockout mouse model (Pdpn
T he lymphatic vascular system is responsible for tissue fluid homeostasis, immune cell trafficking, and intestinal lipid uptake. 1, 2 Peripheral lymphatic capillaries take up interstitial fluid (ie, lymph) that is then filtered through lymph nodes (LN) and drained by lymphatic collecting vessels that converge into the thoracic duct (TD)-the largest lymphatic vessel (LV) in the body-and the right lymphatic trunk, which finally connect to the subclavian veins, where the lymph enters the blood circulation. At these connection points, specialized valves known as lymphovenous valves prevent the flow of blood into the lymphatic circulation. 3, 4 LVs also play key functions in the trafficking of immune cells from the peripheral tissues to the draining LNs, where the initiation of adaptive immune responses occurs. 5 Podoplanin is a small, extensively O-glycosylated, type 1 transmembrane protein expressed by lymphatic endothelial cells (LECs) 6 but not by blood vascular endothelial cells and is therefore a widely used lymphatic-specific marker. Podoplanin is also expressed by follicular reticular cells (FRCs) of secondary lymphoid organs, 7 podocytes of the kidney, 8 alveolar type 1 cells of the lung, and by the choroid plexus epithelium. 9 Moreover, it is expressed in the developing heart of the mouse embryo. 10 Podoplanin is the only described endogenous ligand of the C-type lectin-like receptor 2 (CLEC-2), 11 which is expressed by platelets 12 and activated dendritic cells (DCs). [13] [14] [15] CLEC-2 signaling is involved in platelet activation, 12 DC motility 15 and in the maintenance of vascular integrity, 16 LN structure and development. 17 Podoplanin global knockout mice die shortly after birth because of a failure to inflate their lungs. 18, 19 Several studies described profound defects in the development and patterning of the lymphatic vasculature in these mice. Global podoplanin knockout mice display congenital lymphedema, impaired lymphatic function, dilation and mispatterning of the intestinal and cutaneous lymphatic vasculature, and blood-filled LVs. [20] [21] [22] The latter phenotype has been attributed to the interaction, at midgestation, of podoplanin expressed by LECs with CLEC-2 expressing platelets, inducing platelet activation and formation of thrombi that mediate the proper separation of the nascent lymphatic system from the cardinal vein. 22, 23 These mice also lack most of the LNs that are replaced by blood-filled, poorly organized remnants. 24 In addition, several cardiac defects, including hypoplasia of the myocardium, were described in podoplanin-deficient embryos, [25] [26] [27] and deletion of podoplanin at the 2-cell stage causes cerebral hemorrhaging in embryos. 28 The broad expression of podoplanin, together with the lethal phenotype observed in global podoplanin-deficient mice, suggests an important role for podoplanin in diverse cell types and in the ontogeny of different organs. It has, however, not been possible to date to dissect its direct function specifically in the lymphatic endothelium at late postnatal or adult stages.
To specifically investigate the function of podoplanin in the postnatal lymphatic vasculature, we developed an inducible, lymphatic-specific podoplanin knockout mouse by crossing Pdpn fl/fl mice 28 and Prox1-Cre-ERT2 mice 29 to obtain Pdpn ΔLEC mice. Postnatal deletion of podoplanin was compatible with life and did not affect the maintenance of normal LV morphology and function. Strikingly, however, blood was frequently detected in the TD of Pdpn ΔLEC mice. Moreover, a subset of their LNs, despite maintaining a normal organization, were frequently blood-filled with detection of blood within the LVs, whereas no disruption of high endothelial venule (HEV) integrity was observed. Furthermore, DC migration to LNs after fluorescein isothiocyanate (FITC) challenge was reduced in Pdpn ΔLEC mice, highlighting a role for podoplanin in immune cell trafficking to the LN. Taken together, these results suggest important postnatal functions of LV-expressed podoplanin in preventing retrograde flow of blood into the lymphatic system and in regulating DC migration to LNs after challenge.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Generation of a Conditional, LymphaticSpecific Podoplanin Knockout Mouse Model
Because global constitutive podoplanin knockout mice display a lethal phenotype on most genetic backgrounds, at least in part caused by a failure to inflate their lungs, 18 we generated mice with postnatal deletion of podoplanin specifically in the lymphatic vasculature. To this aim, Pdpn fl/fl mice 28 were crossed with Prox1-Cre-ERT2 mice, 29 which express Cre recombinase under control of the lymphatic specification gene Prox1 30 in response to tamoxifen administration, obtaining the Pdpn ΔLEC line ( Figure 1A ). Postnatal deletion of the podoplanin gene was induced by daily tamoxifen administrations from postnatal day (P) 1 to P3 ( Figure 1A ). Adult Pdpn ΔLEC mice showed efficient podoplanin downregulation in dermal LVs, as assessed by wholemount immunofluorescence stainings for podoplanin and the lymphatic marker LYVE-1 (lymphatic vessel endothelial hyaluronan receptor 1; Figure 1B ; Figure ID in the onlineonly Data Supplement), and by fluorescence-activated cell sorter analysis ( Figure 1C from birth to at least 23 weeks of age; they were not visually distinguishable from wild-type littermates, and their weight was normal (data not shown).
Postnatal Deletion of Podoplanin Does Not Interfere With Lymphatic Patterning
At P7, Pdpn ΔLEC pups appeared normal, and no difference in weight was observed (Figure 2A ). Podoplanin was efficiently downregulated at this time point, as assessed by podoplanin whole-mount stainings of abdominal skin, diaphragm, and mesentery ( Figure IA through IC in the online-only Data Supplement). LV morphology was analyzed by staining whole-mount preparations of abdominal skin ( Figure 2B ), tail skin ( Figure 2C ), and diaphragm ( Figure 2D ) for LYVE-1. Morphometric analyses did not reveal any significant differences in the LYVE-1 + area, number of branch points, number of ring structures, LV diameter, total vessel length, and average branch length ( Figure 2B through 2D).
Adult LVs Are Morphologically and Functionally Normal After Postnatal Deletion of Podoplanin
Next, we investigated the morphology and functionality of adult LVs lacking podoplanin. To this purpose, ear wholemounts of 11-week-old mice were stained for LYVE-1. LV morphology appeared normal in adult Pdpn ΔLEC animals, as no major differences were found in the tissue area covered by LVs, the number of LV branches, the total vessel length, and the average vessel diameter ( Figure 3A) . As a measure of lymphatic function, we injected the lymphatic-specific tracer P20D800 31, 32 intradermally into the ear and monitored its clearance by LVs over time. As quantified by half-life and K rate of the tracer decay, no difference was observed in lymphatic clearance between Pdpn ΔLEC mice and wild-type littermates ( Figure 3B ).
Postnatal Deletion of Podoplanin Results in Blood-Filled LVs and LNs
The LNs of adult Pdpn ΔLEC mice often displayed a bloody appearance (Figure 4A and 4C; Figure IIA and IIB in the online-only Data Supplement). To determine when this phenotype arose, we analyzed animals at different ages, namely, P7, P21, and adults. As shown by the phenotype frequencies in different anatomic locations ( Figure 4B ), at P7, the LNs were never blood-filled and we only observed blood in the TD of 1 of 9 mice analyzed. At weaning age (P21), the phenotype was apparent and, as in adult mice, the LNs located in the neck (auricular and mandibular) and axilla (axillary and brachial) showed the phenotype with higher frequency than the inguinal LNs and flank lymphatic collectors ( Figure 4C ). The mesenteric LNs ( Figure IIB in the online-only Data Supplement) and intestinal LVs ( Figure 4D ) were blood-filled only in adult Pdpn ΔLEC mice and were not affected at P21 or P7. Fluorescence-activated cell sorter analysis revealed an increase in the frequency of red blood cells (identified as CD45 -Ter119 + events) in auricular LNs harvested from adult Pdpn ΔLEC mice (7.7±2.17% of cells) when compared with wild-type littermates (1.3±0.53%), confirming the presence of blood in these LNs ( Figure 4E ).
To determine the origin of bleeding, we performed immunofluorescence analyses for red blood cells (Ter119), LYVE-1, and the pan-endothelial marker CD31 or VE-cadherin on frozen LN sections ( Figure 4F ; Figure IIC Importantly, no red blood cells were observed in the proximity of HEVs, suggesting that extravasation of erythrocytes from these vessels did not occur. Because FRCs lining HEVs retained podoplanin expression in Pdpn ΔLEC mice (Figure III in the online-only Data Supplement, arrowheads), the presence of blood in the LNs was not because of compromised HEV integrity, but because of blood filling of the lymphatic vasculature.
We also analyzed the presence of blood in the TD of Pdpn ΔLEC mice, which was identified by fluorescent lymphatic tracing after intradermal injection of the lymphatic tracer P20D680 31 in both hind paws. Blood was visible by whitelight analysis in the TD in 36.4% (4 of 11) of Pdpn ΔLEC mice ( Figure 4G ) but not in wild-type mice (n=7). In the majority of Pdpn ΔLEC mice (3 of 4), the blood-filled TD was massively dilated ( Figure 4G ). Importantly, only mice that showed blood in the TD also had blood-filled mesenteric LNs ( Figure IB in the online-only Data Supplement). Taken together, these data suggest that the lack of podoplanin on LECs results in retrograde flow of blood from the veins into the lymphatic system.
To investigate whether podoplanin is required throughout life to prevent blood filling of the lymphatic system, we induced gene deletion in adult mice by 5 daily tamoxifen injections and analyzed the phenotype 5 days after the last tamoxifen injection ( Figure IVA in the online-only Data Supplement). With this regimen, podoplanin expression was strongly reduced even though gene deletion was not complete, as a low level of podoplanin expression was detected in some dermal LVs by whole-mount staining ( Figure IVB in the online-only Data Supplement). We did not observe any blood in the LNs, but in one-third of the mice blood filled the TD ( Figure IVC in the online-only Data Supplement). These data indicate that podoplanin is required throughout life to keep the blood from entering the lymphatic system. 
Postnatal Deletion of Podoplanin Does Not Compromise LN Organization
Global podoplanin knockout mice have poorly organized LNs. 24 To assess the contribution of LV podoplanin to LN organization, we analyzed the morphology of Pdpn ΔLEC LNs in more detail. Histological analyses revealed normal B-cell follicle organization in Pdpn ΔLEC LNs, as compared with wildtype controls ( Figure 5A ). Ear draining LNs of Pdpn ΔLEC mice were heavier, whereas the total leukocyte number measured after RBC lysis, the proportions of T cells, and the absolute number of migratory DCs did not differ between the genotypes ( Figure 5B through 5F ). We also analyzed HEVs by immunostaining for the differentiation marker MECA79 and observed a normal HEV morphology in LNs of Pdpn ΔLEC mice ( Figure 5G ). We found heavier LNs in Pdpn ΔLEC mice than in wild-type controls ( Figure 5B ). To assess the relative contribution of the presence of RBC and of the accumulation of fluid to the increased weight observed, we analyzed the wet weight and dry weight of mandibular LNs and calculated the LN fluid content. Both the wet and dry LN weights were increased in Pdpn ΔLEC mice when compared with wild-type controls, and the LN fluid content did not differ between the genotypes ( Figure 5H ). These data, together with the results on total LN cellularity ( Figure 5C ), indicate that the presence of RBC is responsible for the increased LN weight observed in Pdpn ΔLEC mice. ΔLEC mouse with blood-filled intestinal LVs. Scale bars, 1 mm (inset, 100 μm). E, Representative fluorescence-activated cell sorter plots of single cell LN suspensions stained for the red blood cell marker Ter119 and the leukocyte marker CD45. The frequency of red blood cells in Pdpn ΔLEC LNs was significantly higher than in wild-type LNs. Mann-Whitney U test, **P<0.01. F, Confocal images of frozen sections of axillary LN stained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor 1; green), Ter119 (red), and CD31 (cyan). Red blood cells (red) filled LN LVs (green; arrows) in Pdpn ΔLEC samples. Red blood cells were also found inside high endothelial venules (cyan; arrowheads) but never in their proximity. A minimum of 6 animals per genotype and condition were analyzed. Boxed area corresponds to higher power inset. Scale bars, 100 μm (inset, 25 μm). G, The fluorescent tracer P20D680 was used to identify the TD after injection into both hind paws. Blood was present in the TD of 36.4% of Pdpn ΔLEC mice, scale bar: 1 mm. nd indicates not determined.
Postnatal Deletion of Podoplanin Impairs DC Migration
It has been suggested that CLEC-2 deficiency hampers DC migration to the LN. 15 To investigate whether the CLEC-2 binding partner podoplanin on LVs contributes to efficient DC trafficking to the LN, we applied FITC solution to the ears of mice and analyzed its uptake by DCs and their migration to the draining auricular LNs after 18 hours ( Figure 6A ). We found reduced proportions of FITC + DCs (gated as MHCII + CD11c + cells) in the LNs of Pdpn ΔLEC mice when compared with wild-type controls ( Figure 6B ). This reduction was a consequence of impaired DC migration, as there were no differences in the proportion of CD11b + CD11c + dermal DCs in the ear skin of Pdpn ΔLEC mice ( Figure 6C ). Fluorescence-activated cell sorter analysis confirmed that LN DCs expressed CLEC-2 and that Pdpn ΔLEC mice retained normal CLEC-2 expression ( Figure 6D ).
Discussion
Podoplanin is not only a marker of lymphatic endothelium but also expressed by other cell types such as LN FRCs and alveolar type I cells in the lung. 33 Thus, global constitutive podoplanindeficient mice display a complex phenotype characterized by death at birth because of lung abnormalities, heart defects, lack of most LNs, edema, and blood-filled LVs. 18, 20, 22, 24, 26 Here, we generated and characterized a mouse model for the postnatal deletion of podoplanin specifically in LVs.
Podoplanin is the only described endogenous ligand of CLEC-2, 11 and this biochemical interaction has been investigated in detail. The extracellular portion of podoplanin contains conserved domains required for CLEC-2 engagement, 34 which in platelets results in the phosphorylation of the CLEC-2 cytoplasmic tail, activation of the Syk tyrosine kinase, and consequent downstream signaling via SLP-76 (SH2 domain containing leukocyte protein of 76 kDa) and PLCγ2 (phospholipase C gamma 2), leading to platelet activation. 11 It has been proposed that during embryonic development, podoplanin/CLEC-2-induced platelet activation prevents the blood filling of the budding lymphatic system from the cardinal vein. 35 Indeed, mice lacking podoplanin, CLEC-2, or downstream signaling molecules, such as Syk and SLP-76, all display a similar blood-filled lymphatic phenotype. [21] [22] [23] [36] [37] [38] [39] We induced podoplanin deletion during early postnatal days (P1 to P3); since at this time point, the lymphatic system has already separated from the cardinal vein, and lymphatic plexuses are actively maturing in different organs. 40 We did not observe lethality or gross developmental defects up to 23 weeks of age in Pdpn ΔLEC animals, suggesting that postnatal deletion of podoplanin in lymphatic endothelium is compatible with life.
Analysis of P7 pups and adult mice revealed morphologically normal and functional LVs in Pdpn ΔLEC mice, suggesting that podoplanin does not play a major role in the postnatal maturation of LVs or in the maintenance of adult LV morphology and drainage function. Previous analyses of global constitutive podoplanin-deficient mice showed enlarged and disorganized LVs, as well as edema and impaired lymphatic function. 20 In addition, blocking of podoplanin function by administration of podoplanin-Fc during late embryonic development resulted in a less complex diaphragmatic lymphatic network in pups. 41 Thus, it is likely that, early in development, podoplanin functionally contributes not only to the separation of the blood vascular and the lymphatic system but also to LV patterning. However, our data indicate that after birth, podoplanin is dispensable for proper LV maintenance and drainage function. In global podoplanin-deficient mice, where podoplanin is also deleted from LN FRCs, lymphatic function is likely impaired by the lack of LNs. 24 In contrast, in Pdpn ΔLEC mice, LNs are present and are normally organized, indicating that podoplanin expressed by FRCs and not by LECs is responsible for the lack of LN organization observed in global constitutive podoplanin-deficient mice.
The most striking phenotype observed in Pdpn ΔLEC mice was the presence of blood-filled LN LVs especially in the neck and axilla (95.5% and 68.2% of adult Pdpn ΔLEC mice, respectively) and, less frequently, flank collecting LVs (7.6% of adult Pdpn ΔLEC mice) and mesenteric LNs and intestinal LVs (31.8% and 10.6% of adult Pdpn ΔLEC mice, respectively). Moreover, blood was present in the TD of 36.4% of adult Pdpn ΔLEC mice analyzed. Interestingly, LN LVs were never blood-filled in P7 Pdpn ΔLEC mice (ie, 5 days after the last tamoxifen injection) and only 11% of mice showed a blood-filled TD at this time point. At weaning age (P21), the frequency of the phenotype was similar to adult mice, with the exception of the mesenteric LNs and LVs, which were never blood-filled at this time point. These data suggest that, after podoplanin deletion, the blood takes a few weeks to reach the LN LVs and more distal sites, such as the mesentery. Accordingly, when gene deletion was induced in adult mice, LN LVs were not blood-filled 5 days after the last tamoxifen injection, but blood was detected in the TD of 1/3 of the mice, similar to what we observed at P7 after tamoxifen injections at P1 to P3.
Moreover, the incomplete penetrance of this phenotype might be because of partial podoplanin deletion, which can occur when Cre recombination is induced after embryonic development. 42 Efficient gene deletion relies on sufficient tamoxifen bioavailability in a given cell/organ, Cre promoter activity, and expression levels of the target gene and local chromatin conformation at the loxP sites, and it is possible that these parameters vary between different cells. [42] [43] [44] Taken together, these data allowed us to propose a potential mechanism of the blood filling of LVs in Pdpn ΔLEC mice. The observation that the LNs located in the neck and axilla, which are anatomically closer to the lymphovenous valves, were filled by blood with the highest frequency and that the phenotype was more pronounced in adult mice than at P7 suggests that LV expression of podoplanin regulates bloodlymph separation in adults and that loss of podoplanin likely compromises platelet aggregation in the proximity of the lymphovenous valve, allowing filling of blood into the lymphatic system ( Figure V in the online-only Data Supplement). Our observations confirm and extend a recent study that revealed an important function of platelet CLEC-2 in lymphovenous hemostasis. 45 Loss of CLEC-2 in the hematopoietic lineage using fetal liver chimeras, genetic approaches, or antibody treatment caused filling of the TD with blood from the subclavian vein; thus, these mice displayed blood-filled mesenteric LNs and vessels. 45, 46 Our study directly addresses the important role that podoplanin on LECs, as the molecular counterpart of CLEC-2, plays in controlling blood-lymphatic separation in developed animals.
Several reports described blood-filled LNs and Peyer patches in adult mice lacking CLEC-2 specifically in the megakaryocyte/platelet lineage or after treatment with CLEC-2 depleting antibodies. 16, 17, 45 However, in models of CLEC-2 deficiency, LN bleeding was also described to occur because of compromised HEV integrity. 16 It was suggested that podoplanin on FRCs interacts with CLEC-2-expressing platelets, inducing release of sphingosine-1-phosphate that tightens interendothelial junctions in HEVs. 16 Our immunofluorescence analyses of frozen LN sections in Pdpn ΔLEC mice revealed blood cells inside LVs of the LNs, but never in close proximity to HEVs. Moreover, FRCs normally lined HEVs and retained podoplanin expression in Pdpn ΔLEC LNs. These observations indicate that the blood-filled LN phenotype was not caused by disruption of HEV integrity, but solely by blood filling into the LVs of the LNs.
The direct analysis of the lymphovenous valve and the presence of thrombi in its proximity has been recently studied by whole-embryo histology. 45 However, the investigation of this anatomic structure by histology in adult animals is technically challenging because of its deep location in the upper chest, and to the best of our knowledge, has not been described to date. Our detailed anatomic analysis of the affected LNs and major LVs (ie, the TD) that constitute the terminal end of the lymphatic system, together with the published data of models of CLEC-2 deficiency, 45 strongly supports our hypothesis that podoplanin functions at the interface between the lymphatic and the blood vascular system to prevent flow of blood into the lymphatic circulation postnatally (Figure V in the online-only Data Supplement).
Despite the presence of blood-filled LVs in the LN, the lymphatic drainage function was not compromised in Pdpn ΔLEC mice under steady-state conditions, as evaluated by the clearance of an injected tracer from ear skin. Moreover, we could perfuse a lymphatic tracer into the blood-filled TD of Pdpn ΔLEC mice after intradermal injections into the hind paws. Similarly, Hess et al 45 observed fluorescence in the TD of CLEC-2-deficient animals after FITC-dextran injection in the hindlimb, suggesting that forward lymphatic flow was present even when blood filled the lymphatic system in a model of CLEC-2 deficiency. It is possible that this residual forward flow is sufficient to ensure physiological fluid drainage in Pdpn ΔLEC mice, and it would be of interest to test the drainage function in conditions characterized by increased demand of fluid drainage, such as inflammation. Another possible explanation could be that new alternate flow routes may be used to bypass the affected LNs, similar to what has been described in metastasis bearing LNs. 31 
Surprisingly, Pdpn
ΔLEC mice do not show signs of distress or lethality, despite the presence of blood in the LVs. It is not uncommon that the presence of profound lymphatic defects does not translate in lethality, a remarkable example is the K14-sVEGFR3 mouse line, which is viable despite completely lacking dermal LVs and displaying lymphedema. 47 Importantly, we found a reduced DC migration to LNs in response to FITC challenge in Pdpn ΔLEC mice. It has been reported that CLEC-2 expressed by DCs interacts with podoplanin expressed by LECs and FRCs to induce actin cytoskeleton rearrangement and cell motility. 15 Consequently, CLEC-2 − /− fetal liver chimeras or mice lacking CLEC-2 specifically in CD11c + DCs show reduced proportions of DCs migrating to the LNs. 15, 48 Here, we complement these observations made in CLEC-2-deficient mice and reinforce the importance of podoplanin expressed by LVs in DC migration. Importantly, we observed no differences in the number of migratory DCs present in Pdpn ΔLEC mice under steady-state conditions. Similarly, HEV maintenance, which has been linked to DC migration, 49 was not affected. These data suggest that CLEC-2 affects DC migration in the context of induction of inflammation and they are in agreement with published data showing no constitutive CLEC-2 expression in resting DCs, but upregulation on lipopolysaccharide-induced systemic inflammation in a small subset of activated DCs.
14 Taken together, our study highlights an important role of podoplanin in adult LVs: podoplanin prevents blood mixing into the lymphatic system postnatally and contributes to efficient DC migration to the LN in response to inflammation.
